Mentice AB (publ) receives an order of USD 620,000 for simulation solutions and development services

GOTHENBURG, Sweden, Sept. 23, 2022 /PRNewswire/ — Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that a leading global healthcare technology company, has signed an agreement to acquire Mentice VIST® simulation solutions and development services, for an order of USD 620,000.

“Working with leading innovative partners, we value the opportunity to collaborate in this space to achieve the ambition to improve healthcare and ultimately the care for patients”, says Göran Malmberg, CEO and Group president for Mentice, “this project focusing on our Intracardiac Echocardiography (ICE) set of solutions is a development area for Mentice, where we have over the last couple of years developed the world’s leading solutions in this medical area. Our ICE solutions are now used by the majority of the world’s leading medtech industry.”

For more information, please contact:

Göran Malmberg, CEO, Mentice
E-post: [email protected] 
US Mobile. +1 (312) 860 5610
Sweden Mobile +46 (0) 703 09 22 22

About Mentice

Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

This information is information that Mentice AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person, on 22 of August 21.30 CEST, 2022. 

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC

Certified Adviser| FNCA Sweden AB, phone +46 8 528 00 399

https://news.cision.com/mentice-ab

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/mentice-ab/r/mentice-ab–publ–receives-an-order-of-usd-620-000-for-simulation-solutions-and-development-services,c3635382

The following files are available for download:

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.